Dados do Trabalho

Título

UROLOGICAL OUTPATIENT TELEMEDICINE IN AN ONCOLOGIC CANCER HOSPITAL

Introdução e Objetivo

This study examined and compared uro-oncologic outpatient telemedicine (TM) and in person assessment during COVID-19 pandemic.

Método

We retrospectively reviewed the medical records of uro-oncologic outpatients treated in our hospital during the COVID-19 pandemic, from June 3rd, 2020, to December 30th, 2020. Patients were evaluated for a single urologist in both pre and postoperative assessment.

Resultados

869 urological outpatients were evaluated in this period, while 193 (22%) through TM modality. The majority was man (n=747; 85.9%, p=0.002), with prostate cancer disease (n=544; 62.6%, p<0.001) at posttreatment follow-up (n=673; 77.4%, p<0.001). Faults were higher at in-person assessment (12.8% vs 7.2%, p=0.035). 

Conclusão

Telemedicine emerges as a substitute for traditional clinic visits and its expansion will allow ease of access for health services. Our study provides insights into the efficacy of postoperative care offered through TM.

Área

Uro-Oncologia